Lv21
118 积分 2023-02-17 加入
A competing risk predictive model for kidney failure in patients with advanced chronic kidney disease
1天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
3天前
已完结
Calibrating models in economic evaluation: a seven-step approach
10天前
已完结
Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
10天前
已完结
The effect of model selection on cost-effectiveness research: a comparison of kidney function-based microsimulation and disease grade-based microsimulation in chronic kidney disease modeling
10天前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
1个月前
已完结
Long-term outcomes of IgA nephropathy in China
1个月前
已完结
Estimated glomerular filtration rate slope and kidney outcomes in IgA nephropathy
2个月前
已完结
Estimated Glomerular Filtration Rate Slope and Kidney Outcomes in IgA Nephropathy
2个月前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
3个月前
已完结
皖公网安备34019202002308
